Timely referral for device-aided therapy in Parkinson's disease. Development of a screening tool-Reference-Cited by-同舟云学术

Timely referral for device-aided therapy in Parkinson's disease. Development of a screening tool

Published:2023-04 Issue: Volume:109 Page:105359
ISSN:1353-8020
Container-title:Parkinsonism & Related Disorders
language:en
Short-container-title:Parkinsonism & Related Disorders

Author:

Moes Harmen R.^ORCID,ten Kate Jolien M.,Portman Axel T.,van Harten Barbera,van Kesteren Mirjam E.,Mondria Tjeerd,Lunter Gerton^ORCID,Buskens Erik^ORCID,van Laar Teus

Publisher

Elsevier BV

Subject

Neurology (clinical),Geriatrics and Gerontology,Neurology

Reference30 articles.

1. Epidemiology of Parkinson's disease;Tysnes;J. Neural. Transm.,2017

2. Diagnosis and treatment of Parkinson disease: a Review;Armstrong;JAMA, J. Am. Med. Assoc.,2020

3. Motor complications in Parkinson's disease: ten year follow-up study;López;Mov. Disord.,2010

4. Continuous drug delivery in Parkinson's disease;Senek;CNS Drugs,2014

5. When the going gets tough: how to select patients with Parkinson's disease for advanced therapies;Worth;Practical Neurol.,2013

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Are 5-2-1 Delphi criteria and MANAGE-PD useful screening tools for general neurologists for qualification to device-aided therapies in advanced Parkinson’s Disease?;Neurologia i Neurochirurgia Polska;2024-08-28

2. Grasping the big picture: impact analysis of screening tools for timely referral for device-aided therapies;Journal of Neural Transmission;2024-07-15

3. Comment on “Does the 5-2-1 criteria identify patients with advanced Parkinson’s disease? Real-world screening accuracy and burden of 5-2-1-positive patients in 7 countries”;BMC Neurology;2024-06-05

4. Levodopa–Entacapone–Carbidopa Intestinal Gel in the Treatment of Advanced Parkinson’s Disease: A Single Center Real-World Experience;Pharmaceutics;2024-03-25

5. Quality of life assessment when considering the introduction of device-assisted therapies in advanced Parkinson's disease: A retrospective observational cross-sectional study;Journal of the Neurological Sciences;2024-02